AbbVie vs. AstraZeneca: Which Pharma Giant Has the Stronger Earnings Growth Story?
AbbVie Inc. (NYSE:ABBV) and AstraZeneca PLC (NYSE:AZN) are both delivering earnings growth, but their latest results reveal different strengths. AbbVie is benefiting from rapid expansion in its immunology franchise, while AstraZeneca is generating considerable momentum from oncology and rare-disease treatments. According to Yahoo Finance’s latest available valuation snapshots, AbbVie trades at 16.39 times forward earnings, […]
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo